InsiderSignal.AI

InsiderSignal.ai

SER - Serina Therapeutics, Inc.

Insider Sale by Moreadith Randall (Chief Scientific Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Moreadith Randall, serving as Chief Scientific Officer at Serina Therapeutics, Inc. (SER), sold 39,000 shares at $2.50 per share, for a total transaction value of $97,500.00.

This sale represents a 100.00% decrease in Moreadith Randall's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 20, 2026, 1 day after the trade was made.

Serina Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Moreadith Randall

Chief Scientific Officer

Randall Moreadith, M.D., Ph.D. is Chief Scientific Officer at Serina Therapeutics, Inc. (SER), with recent insider trading activity including exercising stock options and selling shares in January 2026.[[1]](https://www.serinatx.com/team/full-name-03)[[2]](https://www.stocktitan.net/sec-filings/SER/form-4-serina-therapeutics-inc-insider-trading-activity-17fa23a53eef.html) He previously served as Chief Development Officer since March 2024, and as President, CEO, and board member from September 2010 to March 2024.[[1]](https://www.serinatx.com/team/full-name-03) Dr. Moreadith brings extensive experience from executive roles such as Chief Development Officer at Nektar Therapeutics, Chief Medical Officer at Cardium Therapeutics and Renovis, and President and co-Founder of ThromboGenics (now Oxurion).[[1]](https://www.serinatx.com/team/full-name-03) He earned his M.D. from Duke University, completed training in Internal Medicine and Cardiovascular Diseases, a Cardiology Fellowship at Duke, and a Ph.D. from Johns Hopkins University, including a Howard Hughes Medical Institute Fellowship in Genetics at Harvard Medical School.[[1]](https://www.serinatx.com/team/full-name-03)

View full insider profile →

Trade Price

$2.50

Quantity

39,000

Total Value

$97,500.00

Shares Owned

0

Trade Date

Thursday, March 19, 2026

4 days ago

SEC Filing Date

Friday, March 20, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Serina Therapeutics, Inc.

Company Overview

No company information available
View news mentioning SER

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4946552

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime